The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global pen needles market was valued at US$ 2.8 Billion in 2021.
We expect the global pen needles market to exhibit a CAGR of 15.01% during 2022-2027.
The rising prevalence of chronic disorders, such as Diabetes Mellitus (DM), that require daily or
weekly administration of medicinal drugs, is primarily driving the global pen needles market.
The sudden outbreak of the COVID-19 pandemic has led to rising utilization of pen needles for self-
administration of drugs, particularly among patients suffering from medical ailments, to avoid
coronavirus infection upon hospital or clinic visits.
Based on the type, the global pen needles market can be segregated into standard pen needles and
safety pen needles. Currently, standard pen needles account for the largest market share.
Based on the needle length, the global pen needles market has been divided into 4mm, 5mm, 6mm,
8mm, 10mm, and 12mm. Among these, 8mm long needles currently exhibit a clear dominance in the
Based on the therapy, the global pen needles market can be bifurcated into insulin, GLP-1, and
growth hormones, where insulin therapy holds the majority of the total market share.
Based on the mode of purchase, the global pen needles market has been categorized into retail and
non-retail. Currently, retail purchase exhibits a clear dominance in the market.
Based on the end user, the global pen needles market can be segmented into hospitals and clinics,
home healthcare, and others. Among these, hospitals and clinics currently represent the largest
On a regional level, the market has been classified into North America, Asia Pacific, Europe, Latin
America, and Middle East and Africa, where Europe currently dominates the global market.
Some of the major players in the global pen needles market include A. Menarini Diagnostics srl,
Advancare Pharma, Arkray Inc., B. Braun Melsungen AG, Becton Dickinson and Company, Hindustan
Syringes & Medical Devices Ltd., HTL Strefa SA, Novo Nordisk A/S, Owen Mumford Ltd., Simple
Diagnostics, Trividia Health Inc. (Sinocare), and Ultimed Inc.
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at